| Date Filed | Type | Description |
| 08/24/2023 |
4
| Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 150,000 shares
@ $1.11, valued at
$166.5k
|
|
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2023 |
4
| Chapman Christopher C JR (President, Chief Med. Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.66, valued at
$498k
|
|
| 06/09/2023 |
4
| Kaplin Adam (Chief Scientific Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 06/09/2023 |
4
| Uzonwanne Jude (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 06/09/2023 |
4
| Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 06/09/2023 |
4
| EAGLE CRAIG (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 475,000 options to buy
@ $1.66, valued at
$788.5k
|
|
| 06/09/2023 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 options to buy
@ $1.66, valued at
$332k
|
|
| 06/09/2023 |
4
| White Billy Joe (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 06/09/2023 |
4
| Rivard Paul (Chief Legal Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.66, valued at
$249k
|
|
| 04/05/2023 |
4
| Chapman Christopher C JR (President, Chief Med. Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 750,000 options to buy
@ $1.55, valued at
$1.2M
|
|
| 12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/29/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 6,734 shares
@ $6.2991, valued at
$42.4k
Bought 3,266 shares
@ $7.0937, valued at
$23.2k
Bought 5,000 shares
@ $7.5543, valued at
$37.8k
|
|
| 11/24/2021 |
4
| Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Bought 15,000 shares
@ $6.03, valued at
$90.5k
|
|
| 10/15/2021 |
4
| Kaplin Adam (Chief Scientific Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 600,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Schreiber Christopher C (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| White Billy Joe (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Uzonwanne Jude (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| EAGLE CRAIG (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Silverman Joshua (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 600,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Chapman Christopher C JR (President, Chief Med. Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 600,000 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 200,000 restricted stock units
@ $0 |
|
| 04/26/2021 |
3
| Williams Caroline C (10% Owner) has filed a Form 3 on MyMD Pharmaceuticals, Inc. |
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/21/2021 |
4
| Kaplin Adam (Chief Scientific Officer) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 154,360 options to buy
@ $2.5913, valued at
$400k
|
|
| 04/21/2021 |
3
| Kaplin Adam (Chief Scientific Officer) has filed a Form 3 on MyMD Pharmaceuticals, Inc. |
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Uzonwanne Jude (Director) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 115,770 options to buy
@ $2.5913, valued at
$300k
|
|
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
3
| Uzonwanne Jude (Director) has filed a Form 3 on MyMD Pharmaceuticals, Inc. |
| 04/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/20/2021 |
4
| Rivard Paul (EVP of Operations, GC) has filed a Form 4 on MyMD Pharmaceuticals, Inc.|
Txns:
| Granted 77,180 options to buy
@ $2.5913, valued at
$200k
Granted 77,180 options to buy
@ $2.5913, valued at
$200k
|
|
| 04/20/2021 |
3
| Rivard Paul (EVP of Operations, GC) has filed a Form 3 on MyMD Pharmaceuticals, Inc. |
|